$20.16
0.251.26%
At Close: -
$20.34
0.180.89%
After Hours: 5:32 PM EDT
15 minutes delayed
Comments
Loading...
Cullinan Therapeutics
CGEMNASDAQ
Latest news for Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cullinan Therapeutics Stock (NASDAQ: CGEM)
Categories: All
Monday, June 03, 2024
Friday, May 24, 2024
Thursday, May 16, 2024
Wednesday, May 01, 2024
Monday, April 29, 2024
- Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Cullinan Therapeutics shares are trading high...
- Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
- Cullinan Therapeutics Announces Appointment O...
Friday, April 26, 2024
- Cullinan Therapeutics shares are trading high...
- Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
Wednesday, April 24, 2024
Wednesday, April 17, 2024
- Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- BTIG Maintains Buy on Cullinan Oncology, Rais...
- United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
- HC Wainwright & Co. Maintains Buy on Cullinan...
Tuesday, April 16, 2024
- Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
- HC Wainwright & Co. Maintains Buy on Cullinan...
- UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
- Market-Moving news for April 16th
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Cullinan Therapeutics shares are trading high...
- Cullinan Therapeutics To Pursue Development O...
- Cullinan Therapeutics Announces Oversubscribe...